Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05728008
Status:
COMPLETED
Last Update Posted:
2023-02-14
First Post:
2023-01-30
Brief Title:
Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis
Sponsor:
Organization:
IRCCS San Raffaele